Search
Selected Filter
Displaying 1–10 of 285 research results
-
Eye On the Cure Research News
Geographic atrophy (GA) is the advanced form of dry age-related macular degeneration (AMD) which causes blindness in one million people in the United States and 5 million worldwide.
This is the first time that a treatment has been approved for this leading cause of blindness.
-
Age-Related Macular Degeneration Research Advances
Retinal Disease Research AdvancesRecent developments in research on age-related macular degeneration.
-
Retinitis Pigmentosa Research Advances
Retinal Disease Research AdvancesRecent developments in research on retinitis pigmintosa.
-
Usher Syndrome Research Advances
Retinal Disease Research AdvancesRecent developments in research on Usher Syndrome.
-
Stargardt Disease Research Advances
Retinal Disease Research AdvancesRecent developments in research on Stargardt disease
-
Leber Congenital Amaurosis Research Advances
Retinal Disease Research AdvancesRecent developments in research on Leber congenital amaurosis
-
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
Eye On the Cure Research NewsThe company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
SparingVision Receives Authorization to Launch US Clinical Trial for its Cone-Preserving Treatment
Eye On the Cure Research NewsThe emerging therapy is designed to work independent of the mutated gene causing retinitis pigmentosa
-
Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
Eye On the Cure Research NewsThe LCA5 gene therapy will be the first emerging Opus treatment to move into a human study
-
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
Eye On the Cure Research NewsThe company is seeking a partner to move the LCA10 program forward
.png)
